SOURCE: CLX Investment Company, Inc.

September 05, 2007 10:30 ET

CLX Investment Company Re-Launches Monthly Investor Newsletter Featuring Q and A With New CEO of Zonda, Incorporated

MURRIETA, CA--(Marketwire - September 5, 2007) - CLX Investment Company, Inc. (OTCBB: CLXN) today announced that it has released its re-launched monthly investor newsletter with a September 2007 edition, which includes a question and answer feature with the Vera Leonard, the new chief executive officer of Zonda, Incorporated. Zonda, in which CLX currently holds a 46% equity position, is a developer and manufacturer of unique diagnostic tests for both the medical and non-medical markets.

A PDF version of the newsletter can be viewed on the company's corporate website at A notification of the newsletter's release has been sent to subscribers to CLX's email alert system.

Ms. Leonard, who has considerable successful experience in leadership positions with major medical manufacturing and distribution companies, was introduced as Zonda's new chief executive officer in early August. In the question and answer feature, Ms. Leonard discusses what she sees as the potential of Zonda's enzymatic detection technology to become the cutting-edge new technology for the medical community. Ms. Leonard also provides additional details regarding her background and experience in the medical supply industry.

Zonda is the major focus of the newsletter, primarily due to the fact that CLX and Zonda have entered into an initial agreement in the form of a letter of intent under which CLX would acquire the remaining issued and outstanding shares of Zonda. Once the remaining due diligence is complete, the companies expect to reach a definitive agreement regarding the acquisition.

"We are pleased to provide this additional information to our shareholders through the September 2007 edition of our investor newsletter, particularly the sections that feature Vera Leonard and her discussion of Zonda," stated Steven R. Peacock, consultant CEO of CLX Investment Company. "While CLX management has consistently expressed confidence that Zonda has the potential to develop into a significant company in the medical supply industry, we believe that Ms. Leonard's viewpoint carries additional weight due to her successful experience with numerous companies in that industry. We firmly believe that she is the best person to be at the helm of Zonda, and we are pleased to feature her in this newsletter edition."

The newsletter also reviews a recent announcement by ActionView International, in which CLX owns over 6 million shares of common stock, regarding an agreement under which ActionView would become the public vehicle for the entrance of Dalian Chuming Group Co., LTD, a major pork producer in China, into the U.S. markets. Dalian Chuming Group Co., LTD is a private Chinese company that is seeking a listing in the U.S. public markets through a reverse merger transaction.

To sign up to receive information by email directly from CLX Investment Company when new press releases, investor newsletters, SEC filings, or other information is disclosed, please visit

About CLX Investment Company

CLX Investment Company ( holds a 46% equity interest in Zonda, Inc. CLX has also invested, and holds a common stock position, in ActionView International, Inc. (, a publicly traded global manufacturer and marketer of "smart" scrolling advertising billboards.

All statements included in this release, including statements regarding potential future plans and objectives of CLX Investments are forward-looking statements. Such statements are necessarily subject to risks and uncertainties, some of which are significant in scope and nature beyond CLX Investments' control. There can be no assurance that such statements will prove accurate. Actual results and future events could differ materially from those anticipated in such statements depending on many factors. Historical results are not necessarily indicative of future performance.

Contact Information

  • Contact:
    Gemini Financial Communications
    A. Beyer
    Email Contact